VAI-SU2C Epigenetics Dream Team
36 results.
Cancer research saves lives.
For the first time, the five-year survival rate for all cancers combined has hit 70% among people diagnosed from 2015–2021 in…
In 2025, VAI continued to build scientific momentum and drive discoveries that deepen our understanding of human health. With the addition of new faculty and…
The past year at Van Andel Institute can be summed up in two words: “growth” and “impact.”
We’ve expanded our research capacity by adding new…
MEMPHIS, Tenn. (Oct. 10, 2024) — Immunotherapy, using a patient’s own immune system to treat disease, has shown promise in some patients with cancer but…
To say that immunotherapies have been a game-changer for cancer feels like an incredible understatement.
These powerful treatments, which work by bolstering the immune…
GRAND RAPIDS, Mich. (March 27, 2024) — A pair of medications that make malignant cells act as if they have a virus could hold new promise for…
Since October 2014, the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team has supported and launched breakthrough clinical trials that explore potential new…
GRAND RAPIDS, Mich. (Nov. 1, 2022) — A pair of cancer medications that act as a one-two punch against malignant cells demonstrated increased survival in…